SOLIACS: Solian Solution in the Acute Setting
During this study the efficacy and safety profile will be evaluated of the use of amisulpride in the form of a solution in schizophrenic patients with an acute episode.
The main purpose of the study is to observe the anti-psychotic effect of amisulpride as a solution during the first days of an acute episode of schizophrenia.
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Solian Solution to Treat Schizophrenic Patients During an Acute Episode|
- *analyze the antipsychotic efficacy of amisulpride solution in the first days of an acute schizophrenic episode.
- *analyse the safety profile of amisulpride solution in treatment of schizophrenics with an an acute episode.
|Study Start Date:||June 2005|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00245674
|Study Director:||Dr. Christian Fassotte, M.D.||Sanofi|